ArticleFrontiers in oncology2026

Efficacy and safety of combined TACE-HAIC and targeted immunotherapy in primary liver cancer with portal vein tumor thrombus.

Shaoqin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.